Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of antidepressants and antipsychotic drugs. Its structure supports the formation of bioactive molecules that interact with central nervous system receptors. Commonly employed in medicinal chemistry for constructing beta-amino ketone frameworks, which are found in several active drug compounds. Also utilized in research settings for designing novel analogs with improved metabolic stability and binding affinity. The presence of the trifluoromethyl group enhances lipophilicity and resistance to oxidative degradation, making it valuable in optimizing drug candidates for better pharmacokinetic profiles.